The roles of tissue-resident macrophages in sepsis-associated organ dysfunction

Yulei Gao1,2, Xin Tian3,4, Xiang Zhang5

  • 1Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, P. R. China.

Heliyon
|November 29, 2023
PubMed

Insights

Tissue-resident macrophages (TRMs) play a dual role in sepsis, acting as both protectors and contributors to organ injury. Modulating TRMs offers a promising therapeutic strategy to mitigate sepsis, septic shock, and sepsis-associated organ dysfunction (SAOD).

Area of Science:

  • Immunology
  • Pathophysiology
  • Cell Biology

Background:

  • Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection.
  • Tissue-resident macrophages (TRMs) are critical immune cells residing in non-lymphoid tissues, originating from early embryonic progenitors.
  • TRMs are essential for local tissue homeostasis and defense against various insults, including infection.

Purpose of the Study:

  • To review the pathophysiological roles of TRMs in the development and progression of sepsis.
  • To explore the dual "angel" and "demon" functions of TRMs in sepsis-induced organ injury.
  • To propose TRM modulation as a potential therapeutic strategy for sepsis, septic shock, and SAOD.

Main Methods:

  • Literature review summarizing existing research on TRMs and sepsis.
  • Analysis of pathophysiological mechanisms linking TRMs to organ dysfunction in sepsis.
  • Synthesis of evidence supporting TRM modulation for sepsis treatment.

Main Results:

  • TRMs exhibit context-dependent roles in sepsis, contributing to both protective immunity and detrimental inflammation.
  • TRM function and phenotype vary across different organs during sepsis.
  • Dysregulated TRM activity is implicated in sepsis-associated organ dysfunction (SAOD) and septic shock.

Conclusions:

  • TRMs are key players in sepsis pathogenesis, influencing disease severity and outcomes.
  • Targeting TRMs in various organs presents a novel therapeutic avenue for managing sepsis and its complications.
  • Further research into TRM-specific mechanisms is crucial for developing effective immunomodulatory therapies.